Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records-Reference-Cited by-同舟云学术

Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records

Published:2019-09-08 Issue:10 Volume:33 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Lentine Krista L.¹^ORCID,Koraishy Farrukh M.¹,Sarabu Nagaraju²^ORCID,Naik Abhijit S.³^ORCID,Lam Ngan N.⁴,Garg Amit X.⁵,Axelrod David⁶^ORCID,Zhang Zidong¹^ORCID,Hess Gregory P.⁷^ORCID,Kasiske Bertram L.⁸,Segev Dorry L.⁹,Henderson Macey L.⁹^ORCID,Massie Allan B.⁹,Holscher Courtenay M.⁹^ORCID,Schnitzler Mark A.¹

Affiliation:

1. Center for Abdominal Transplantation Saint Louis University School of Medicine St. Louis MO USA

2. Division of Nephrology Department of Medicine University Hospitals Cleveland Medical center Cleveland OH USA

3. Division of Nephrology Department of Medicine University of Michigan Ann Arbor MI USA

4. Division of Nephrology Department of Medicine University of Alberta Edmonton AB Canada

5. Division of Nephrology Department of Medicine Western University London ON Canada

6. University of Iowa Transplant Institute University of Iowa School of Medicine Iowa City IA USA

7. Drexel College of Medicine Drexel University Philadelphia PA USA

8. Department of Medicine Hennepin County Medical Center Minneapolis MN USA

9. Division of Transplantation, Department of Surgery Johns Hopkins University Baltimore MD USA

Funder

Health Resources and Services Administration

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.13696

Reference42 articles.

1. KDIGO clinical practice guideline on the evaluation and care of living kidney donors;Lentine KL;Transplantation,2017

2. Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors

3. Renal Function Profile in White Kidney Donors: The First 4 Decades

4. OPTN (Organ Procurement and Transplantation Network)/UNOS (United Network for Organ Sharing).OPTN Policies Policy 14: Living Donation.http://optn.transplant.hrsa.gov/governance/policies/. Accessed July 7 2019.

5. Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bariatric Surgery in Severely Obese Kidney Donors Before Kidney Transplantation: A Retrospective Study;Transplantation;2023-08-21

2. Recommendations for living donor kidney transplantation;Nefrología (English Edition);2022-12

3. Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study;PLOS ONE;2022-11-18

4. Change in Body Mass Index and Attributable Risk of New Onset Hypertension among Obese Living Kidney Donors;Annals of Surgery;2022-08-10

5. Evaluation of the Living Kidney Donor Candidate;Nephrology Self-Assessment Program;2022-08